Inclusion of genotype with fundus phenotype improves accuracy of predicting choroidal neovascularization and geographic atrophy

Ophthalmology

Volumn 120, Issue 9, 2013, Pages 1880-1892

  Perlee, Lorah T ^a   Bansal, Aruna T ^b   Gehrs, Karen ^c   Heier, Jeffrey S ^d   Csaky, Karl ^e   Allikmets, Rando ^f   Oeth, Paul ^a   Paladino, Toni ^a   Farkas, Daniel H ^g   Rawlings, P Lyle ^g   Hageman, Gregory S ^h  

^a SEQUENOM INC   (United States)

^b Acclarogen Ltd   (United Kingdom)

^c UNIVERSITY OF IOWA   (United States)

^d OPHTHALMIC CONSULTANTS OF BOSTON   (United States)

^e TEXAS RETINA ASSOCIATES   (United States)

^f Och Spine at New York Presbyterian Hospitals   (United States)

^g Sequenom Center for Molecular Medicine   (United States)

^h UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACCURACY; AGED; COHORT ANALYSIS; CONFERENCE PAPER; CONTROLLED STUDY; FEMALE; GENETIC ASSOCIATION; GENETIC MARKER; GEOGRAPHIC ATROPHY; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; SUBRETINAL NEOVASCULARIZATION;

AGED; AGED, 80 AND OVER; APOLIPOPROTEINS; CHOROIDAL NEOVASCULARIZATION; COMPLEMENT FACTOR H; COMPLEMENT SYSTEM PROTEINS; DISEASE PROGRESSION; EYE PROTEINS; FEMALE; FUNDUS OCULI; GENETIC MARKERS; GENOTYPE; GEOGRAPHIC ATROPHY; HUMANS; MACULAR DEGENERATION; MALE; MIDDLE AGED; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEINS; REPRODUCIBILITY OF RESULTS; RISK FACTORS;

EID: 84883763387     PISSN: 01616420     EISSN: 15494713     Source Type: Journal    
DOI: 10.1016/j.ophtha.2013.02.007     Document Type: Conference Paper

References (24)

1. National Eye Institute Prevalence of Age-Related Macular Degeneration in the United States [NEI Statistics and Data] http://www.nei.nih.gov/eyedata/pbd4. asp Accessed February 4, 2013
2. S.C. Tomany, J.J. Wang, and R. van Leeuwen Risk factors for incident age-related macular degeneration: pooled findings from 3 continents Ophthalmology 111 2004 1280 1287
3. AMD Alliance International Basic facts about AMD http://www.amdalliance. org/information-overview-basic-facts.html Accessed February 4, 2013
4. J.H. Lim, S.S. Wickremasinghe, and J. Xie Delay to treatment and visual outcomes in patients treated with anti-vascular endothelial growth factor for age-related macular degeneration Am J Ophthalmol 153 2012 678 686
5. P.S. Muether, R. Hoerster, and M.M. Hermann Long-term effects of ranibizumab treatment delay in neovascular age-related macular degeneration Graefes Arch Clin Exp Ophthalmol 251 2013 453 458
6. P.S. Muether, M.M. Hermann, K. Koch, and S. Fauser Delay between medical indication to anti-VEGF treatment in age-related macular degeneration can result in a loss of visual acuity Graefes Arch Clin Exp Ophthalmol 249 2011 633 637
7. J.M. Seddon, R. Reynolds, and Y. Yu Risk models for progression to advanced age-related macular degeneration using demographic, environmental, genetic, and ocular factors Ophthalmology 118 2011 2203 2211
8. M.L. Klein, P.J. Francis, and F.L. Ferris III Risk assessment model for development of advanced age-related macular degeneration Arch Ophthalmol 129 2011 1543 1550
9. G.S. Hageman, K. Gehrs, and S. Lejnine Clinical validation of a genetic model to estimate the risk of developing choroidal neovascular age-related macular degeneration Hum Genomics 5 2011 420 440
10. L.C. McCarthy, P.J. Newcombe, and J.C. Whittaker Predictive models of choroidal neovascularization and geographic atrophy incidence applied to clinical trial design Am J Ophthalmol 154 2012 568 578
11. F. Grassmann, L.G. Fritsche, and C.N. Keilhauer Modelling the genetic risk in age-related macular degeneration PLoS ONE [serial online] 7 2012 e37979 http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0037979 Accessed February 4, 2013
12. Y. Yu, R. Reynolds, and B. Rosner Prospective assessment of genetic effects on progression to different stages of age-related macular degeneration using multistate Markov models Invest Ophthalmol Vis Sci 53 2012 1548 1556
13. K.L. Spencer, L.M. Olson, and N. Schnetz-Boutaud Using genetic variation and environmental risk factor data to identify individuals at high risk for age-related macular degeneration PLoS One [serial online] 6 2011 e17784 http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0017784 Accessed February 4, 2013
14. Y. Chen, J. Zeng, and C. Zhao Assessing susceptibility to age-related macular degeneration with genetic markers and environmental factors Arch Ophthalmol 129 2011 344 351
15. J.M. Seddon, R. Reynolds, and B. Rosner Associations of smoking, body mass index, dietary lutein, and the LIPC genetic variant rs10468017 with advanced age-related macular degeneration Mol Vis [serial online] 16 2010 2412 2424 http://www.molvis.org/molvis/v16/a259/ Accessed February 4, 2013
16. A.E. Hughes, N. Orr, and C. Patterson Neovascular age-related macular degeneration risk based on CFH, LOC387715/HTRA1, and smoking PLoS Med [serial online] 4 2007 e355 http://www.plosmedicine.org/article/metrics/info%3Adoi%2F10. 1371%2Fjournal.pmed.0040355 Accessed February 4, 2013
17. A.E. Hughes, N. Orr, and H. Esfandiary A common CFH haplotype, with deletion of CFHR1 and CFHR3, is associated with lower risk of age-related macular degeneration Nat Genet 38 2006 1173 1177
18. G.S. Hageman, D.H. Anderson, and L.V. Johnson A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration Proc Natl Acad Sci U S A 102 2005 7227 7232
19. L. Sobrin, S. Ripke, and Y. Yu Heritability and genome-wide association study to assess genetic differences between advanced age-related macular degeneration subtypes Ophthalmology 119 2012 1874 1885
20. S. Yanagisawa, N. Kondo, and A. Miki Difference between age-related macular degeneration and polypoidal choroidal vasculopathy in the hereditary contribution of the A69S variant of the age-related maculopathy susceptibility 2 gene (ARMS2) Mol Vis [serial online] 17 2011 3574 3582 http://www.molvis.org/ molvis/v17/a384/ Accessed February 4, 2013
21. Age-Related Eye Disease Study Research Group A simplified severity scale for age-related macular degeneration: AREDS report no. 18 Arch Ophthalmol 123 2005 1570 1574
22. E.M. Stone, A.J. Aldave, and A.V. Drack Recommendations for genetic testing of inherited eye diseases: report of the American Academy of Ophthalmology Task Force on Genetic Testing Ophthalmology 119 2012 2408 2410
23. Age-Related Eye Disease Study Research Group The Age-Related Eye Disease Study (AREDS): design implications AREDS report no. 1 Control Clin Trials 20 1999 573 600
24. Age-Related Eye Disease Study Research Group The Age-Related Eye Disease Study severity scale for age-related macular degeneration: AREDS report no. 17 Arch Ophthalmol 123 2005 1484 1498